Scleroderma or progressive systemic sclerosis (PSS) is a very complex condition, with a major autoimmune part. Food allergies need to become ruled out as the potential cause. Pulsed electromagnetic fields [PEMFs] could possibly be effective for controlling certain aspects of scleroderma but would not be likely to cure or shut off the condition. Basically, PEMFs would be worthwhile to control a lot of the complications and side effects on the scleroderma and may actually slow down its progression. There is no reason which it could not be used alongside some other therapies, including disease modifying sessions. In terms of service for using PEMFs intended for scleroderma, I was able to get two studies that considered its use. I have no testimonial experience treating this condition.
The first study integrated 20 scleroderma patients having Raynaud’s syndrome. They were treated which has a PEMF applied to the particular spine at C4-Th7 and Th10-L2 vertebrae. They found that 95% had improvement more than palmar sweating, cold sensitivity, reflexes and ulnar neural conduction. Velocities increased by 5-7m/s.
The second controlled clinical trial looked over treatment with a different PEMF in combination with other conventional and alternative therapies, which included physical therapies, supplements, and massage. This study had 80 patients, 52 of whom got local thickening/induration and 30 head multiple areas concerned. The study had a fundamental group and an assessment group, with 40 in every, and a third control number of healthy people. The therapy group had the standard therapies plus PEMFs, whereas the control group only had the usual therapies. Treatments were applied any day for a length of 12 procedures. They were evaluated utilizing clinical and immunological screening. The treatment group got full recovery in 16 of 40 individuals, with significant improvement within another 22 (95% showing no less than some improvement). The control group had full recovery in mere 10 and significant improvement in 19 (73% showing no less than some improvement). There was a highly statistically significant improvement in immune indices in comparison to the control group, including immunoglobulins, blast transforming activity regarding lymphocytes and complement. They concluded that PEMFs facilitate clinical together with immunological improvements in scleroderma/PSS.
While these studies point out benefit in scleroderma patients with a limited course of use, it would be anticipated that continuing benefit would be seen with continued use over the long-term. It may be important to continue traditional disease modifying agents (DMARD treatments) at the start, depending on the severity from the scleroderma, and then gradually taper these people off with continued PEMF utilize and monitoring of professional medical parameters. Adding oral type I collagen supplementation for the treatment protocol may also boost benefit of PEMF’s to further improve the thickening of your tissues, since PEMFs, have been found to raise scars caused by intense collagen deposition
For more details do checkout at magnopro